Alectinib Reactions 1680, p21 - 2 Dec 2017 Acquired resistance to alectinib during treatment of AKK-positive lung tumour: case report A 51-year-old man had acquired resistance to alectinib treatment of during AKK-positive lung tumour with alectinib [dosage and route not stated]. The man, who had AKK-positive lung tumour, was started on first-line treatment with alectinib. However, he acquired resistance to alectinib in three months. Subsequently, the man was started on ceritinib or crizotinib, which showed only a moderate and temporary effect. Later, he died of unspecified reasons [outcome of reaction not stated]. Author comment: "However, acquired resistance to alectinib is inevitable" "The lung tumors acquired resistance to first-line treatment of alectinib in three months" Makimoto G, et al. A comprehensive analysis of autopsied specimens and patient derived cell lines in ALK-positive lung cancers with rapid acquired resistance to alectinib. Cancer Research 77 (Suppl. 13): abstr. 3164, Jul 2017. Available from: URL: [abstract] - Japan 803284842 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial